The aim is to revolutionise the way medical research is conducted by taking an engineering-led approach under the umbrella of systems biology, in which rigorous mathematical models are derived from experimental data and used to make predictions, about disease for example, that can be tested and then refined.
Ultimately such methods will be applied to all major problems in biology, but for the upcoming EuroBioForum, the focus will be on one field, metabolic syndrome, as a proving ground for the new approach, according to Professor Roel van Driel from the University of Amsterdam and Netherlands Institute for Systems Biology and co-chair of the ESF Forward Look on Systems Biology. He is also the proposer of the Systems Biology to combat Metabolic Syndrome (SBMS) initiative.
The SBMS plan is to establish a coordinated €175 million 10-year European programme with the ultimate ambition of developing effective therapies, including diet and lifestyle as well as drugs, that both reduce the risk of acquiring metabolic syndrome conditions, and bring significant relief for existing sufferers. Metabolic syndrome embraces a range of serious inter-related conditions including obesity and diabetes. The programme would adopt an engineering-led data-driven approach to systematically unravel the combined molecular, cellular, and organismal basis of the individual metabolic syndrome components, according to van Driel. These components include insulin resistance, associated with Type II diabetes, the most common form of diabetes in the western word; weight gain; glucose intolerance; high blood pressure; and high blood cholesterol (dyslipedemia), which can cause atherosclerosis, a disease of the blood vessels.
The radical departure of SBMS from the traditional ad hoc approach to medical research was motivated by a growing appreciation of how complex all important biological problems are, according to van Driel. This realisation has developed since completion of major genome sequencing projects, which created huge amounts of data, but as yet little more understanding of how biology works at a fundamental level.
The key to success of SBMS will lie in creating a coordinated framework of world class projects. Some of these will draw from existing national and Europe-wide programmes that are concentrating at present on specific aspects of metabolic syndrome. “We will select those that are fit for a systems biology approach and create a strong and well-focused consortium of European research groups,” said van Driel, who conceded that this was far from trivial.
Indeed the challenge posed by systems biology was more organisational than scientific, van Driel insisted. “It’s not primarily a science problem. We are good at doing the science itself, but very poor at getting organised.”
However, EuroBioForum’s role is to tackle this organisational challenge with a new approach. EuroBioForum is the annual conference of EuroBioFund, which was launched in 2006 by the European Science Foundation with support from the EU through the Sixth Framework Programme, to bring together public and private sources of funding to catalyse the development of large scale pan-European life science research programmes.
The SBMS project will be a testing ground both for both EuroBioFund’s approach to research funding, and the new methods driven by systems biology, aiming to make research more clearly defined and based on computational models that make testable predictions and are capable of continuous refinement in the light of emerging data. “We aim to change the way biomedical research is done,” said van Driel.
Thomas Lau | alfa
Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences
What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...
20.03.2017 | Event News
14.03.2017 | Event News
07.03.2017 | Event News
24.03.2017 | Materials Sciences
24.03.2017 | Physics and Astronomy
24.03.2017 | Physics and Astronomy